Clinical trialsNew law to speed up clinical trialsWith a new law, the German government wants to increase the number of clinical trials conducted in Germany and make the country number one in Europe again. more ➔
autoimmune diseaseGut bacteria seed autoimmunity-inducersA bacterium of the gut microbiome seems to spark an autoimmune disease in the kidneys by leaking antigens that trigger the immune system. more ➔
Cultivated FoodInnocent Meat bags €3m financingCultivated meat producer Innocent Meat GmbH has cashed in €3m in funding from Venture Capital Fonds MV and an anonymous business angel. more ➔
NeurologySpanish Ferrer SA pays €122.5m for ALS...Spanish Ferrer Internacional, SA has aquired the ex-US rights to VRG50635 from Verge Genomics Inc to commercialise the oral Phase I experimental ALS treatment. more ➔
acquisitionNovo Nordisk to acquire Cardior Pharmaceut... Novo Nordisk is set to acquire German miRNA blocker specialist Cardior Pharmaceuticals GmbH for up to €1.025bn including milestone payments. more ➔
Rare diseaseNDM Pharma provides POC for NMD670Researchers at NDM Pharma A/S and Aarhus University have demonstrated that their oral CIC-1 blocker NMD670 restores crosstalk between neurons and muscles in Myasthenia gravis. more ➔
gene therapyRoche opens €90m gene therapy developmen...Basel-headquartered Roche AG has inaugurated a brand new €90m gene therapy development centre in Penzberg near Munich. more ➔
acquisitionAstraZeneca to take over Fusion Therapeut...British pharma giant AstraZeneca has announced to acquire radio-conjugate specialist Fusion Therapeutics Inc for US$2bn upfront. more ➔
financingSenisca Ltd raises £3.7m seed moneyExeter-based university spin-out Senisca Ltd has added £3.7m seed money to a £1.1m not dilutive funding to advance its pipeline of drugs targetting RNA splicing dysregulation. more ➔
acquisitionAstraZeneca to acquire Amolyt Pharma for u...French endocrine diseases specialist Amolyt Pharma SA has entered into a take-over agreement by AstraZeneca. more ➔
